Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Some medications are absolutely contraindicated for combined use. For other medications, even if drug interactions may occur, they can still be used under the guidance of a physici···【more】
Article source：Captain MedicineRelease date：2026-02-05Recommended：223
Cabozantinib is a non-chemotherapy prescription medication classified as a tyrosine kinase inhibitor (TKI). It is administered as a tablet, taken once daily, or as directed by a he···【more】
Article source：Captain MedicineRelease date：2026-02-05Recommended：292
Patients should take pirfenidone with meals at a fixed time every day to reduce the incidence of adverse reactions such as nausea and dizziness. For patients taking strong or moder···【more】
Article source：Captain MedicineRelease date：2026-02-04Recommended：288
The most common side effects of pirfenidone include upper respiratory tract infection, fatigue, headache, dizziness, decreased appetite, sinusitis, insomnia, and weight loss.Are th···【more】
Article source：Captain MedicineRelease date：2026-02-04Recommended：213
Pirfenidone is an oral antifibrotic medication primarily used for the treatment of idiopathic pulmonary fibrosis (IPF).Drug Interactions of PirfenidoneCYP1A2 InhibitorsConcomitant ···【more】
Article source：Captain MedicineRelease date：2026-02-04Recommended：226
The safety of pirfenidone has been evaluated in more than 1,400 subjects, of whom over 170 received pirfenidone treatment for more than 5 years in clinical trials.Precautions for U···【more】
Article source：Captain MedicineRelease date：2026-02-04Recommended：305
Nintedanib is a multi-targeted tyrosine kinase inhibitor; it can reduce the activity of fibroblasts in patients with idiopathic pulmonary fibrosis (IPF).What should be noted during···【more】
Article source：Captain MedicineRelease date：2026-02-03Recommended：278
In 2019, nintedanib became the first therapy approved by the FDA to slow the rate of lung function decline in adults with SSc-ILD.What side effects may occur with nintedanib?The fo···【more】
Article source：Captain MedicineRelease date：2026-02-03Recommended：294
Nintedanib is a small-molecule tyrosine kinase inhibitor that binds to growth factor receptors and inhibits the proliferation of fibroblasts.How to Take NintedanibTake this medicat···【more】
Article source：Captain MedicineRelease date：2026-02-03Recommended：240
Nintedanib is indicated for the treatment of diseases that cause scarring and hardening of the lungs, leading to breathing difficulties. It acts by inhibiting pathological changes ···【more】
Article source：Captain MedicineRelease date：2026-02-03Recommended：244
Elacestrant is the world’s first approved oral selective estrogen receptor degrader (SERD), indicated for the treatment of adult patients with estrogen receptor-positive (ER+), hum···【more】
Article source：Captain MedicineRelease date：2026-02-02Recommended：261
Before starting elacestrant, discuss any questions or concerns with your medical team.What is the recommended dose of Elacestrant?Take one 345 mg tablet once daily. Patients should···【more】
Article source：Captain MedicineRelease date：2026-02-02Recommended：276
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
